Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection

Cancer Commun (Lond). 2022 Dec 24;10.1002/cac2.12398. doi: 10.1002/cac2.12398. Online ahead of print.

Authors

Fuchen Liu¹, Xiaochen Feng¹, Jin Du¹, Minghao Ruan¹, Hui Liu¹

Affiliation

¹ The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Third Affiliated Hospital, Second Military Medical University, Naval Medical University, Shanghai, P. R. China.

No abstract available

Publication types

Letter

Grant support